Bionano Genomics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Revenue Outlook for 2022

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Bionano Genomics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Revenue Outlook for 2022

Bionano Genomics (BNGO) PT Lowered to $8 at Ladenburg Thalmann

March 2, 2022 7:45 AM EST

Ladenburg Thalmann analyst Jeffrey Cohen lowered the price target on Bionano Genomics (NASDAQ: BNGO) to $8.00 (from $9.50) while maintaining a Buy rating following results.

The analyst commented, "Bionano announced Q4- and FY-2021 financial results and held a conference call to discuss. For the... More

BioNano Genomics, Inc. (BNGO) Reports Q4 Net Loss of $29.5M

March 1, 2022 4:13 PM EST

BioNano Genomics, Inc. (NASDAQ: BNGO) reported Q4 net loss of $29.5M. Revenue for the quarter came in at $6.3 million versus the consensus estimate of $5.57 million.

GUIDANCE:

BioNano Genomics, Inc. sees FY2022 revenue of $24-27 million.

For earnings history and earnings-related data on BioNano Genomics, Inc. (BNGO) click here.

... More